Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Week in Review: CCTA on ACC expo floor gives cardiologist wake-up call | Reaction to CMS TAVR changes | Recalls and new AI

News You Need to Know Today
Week in Review: CCTA on ACC expo floor gives cardiologist wake-up call | Reaction to CMS TAVR changes | Recalls and new AI
Saturday, June 20, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

CCTA scan at conference gives cardiologist a wake-up call

Cardiologist Michael McMullan, MD, was surprised by his own CCTA results, highlighting the substantial impact these scans can make on patient care. 

READ MORE >
Cardiologist Michael McMullan explains his surprise about high levels of soft coronary plaque seen on CCTA despite years of intensive statin therapy. #YesCCT
Share on Twitter Share on Facebook Share on Linkedin

CCTA scan at conference gives cardiologist a wake-up call

Share on Twitter Share on Facebook Share on Linkedin
Cardiologist Michael McMullan explains his surprise about high levels of soft coronary plaque seen on CCTA despite years of intensive statin therapy. #YesCCT
Cardiologist Michael McMullan, MD, was surprised by his own CCTA results, highlighting the substantial impact these scans can make on patient care. 
READ MORE >

Cardiologists and surgeons share early feedback after CMS proposed sweeping TAVR changes

Major TAVR policy changes appear to be on the way—should clinicians be excited or concerned? Leading U.S. medical societies are sharing their early reactions.

READ MORE >
Heart cardiologists doctors surgery
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists and surgeons share early feedback after CMS proposed sweeping TAVR changes

Share on Twitter Share on Facebook Share on Linkedin
Heart cardiologists doctors surgery
Major TAVR policy changes appear to be on the way—should clinicians be excited or concerned? Leading U.S. medical societies are sharing their early reactions.
READ MORE >

'Not sustainable': The real impact of RVU cuts in electrophysiology

Despite a substantial increase in demand for electrophysiologists, payments for their services have remained stagnant. 

READ MORE >
Joshua R. Silverstein, MD, FHRS, a cardiac electrophysiologist at Allegheny Health Network Cardiovascular Institute, explains the real-world impacts of Centers of Medicare and Medicaid Services (CMS) RVU cuts in electrophysiology.
Share on Twitter Share on Facebook Share on Linkedin

'Not sustainable': The real impact of RVU cuts in electrophysiology

Share on Twitter Share on Facebook Share on Linkedin
Joshua R. Silverstein, MD, FHRS, a cardiac electrophysiologist at Allegheny Health Network Cardiovascular Institute, explains the real-world impacts of Centers of Medicare and Medicaid Services (CMS) RVU cuts in electrophysiology.
Despite a substantial increase in demand for electrophysiologists, payments for their services have remained stagnant. 
READ MORE >

More than 11K bottles of blood pressure drug recalled

Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness. 

READ MORE >
pills-384846_960_720.jpg
Share on Twitter Share on Facebook Share on Linkedin

More than 11K bottles of blood pressure drug recalled

Share on Twitter Share on Facebook Share on Linkedin
pills-384846_960_720.jpg
Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness. 
READ MORE >

Resistance training reduces heart attack risk in women

Researchers explored data from more than 117,000 women, tracking several lifestyle habits over an extended period of time.

READ MORE >
exercise aerobic training fitness resistance training older woman
Share on Twitter Share on Facebook Share on Linkedin

Resistance training reduces heart attack risk in women

Share on Twitter Share on Facebook Share on Linkedin
exercise aerobic training fitness resistance training older woman
Researchers explored data from more than 117,000 women, tracking several lifestyle habits over an extended period of time.
READ MORE >

High-intensity ultrasound technology for calcified valve leaflets makes debut in Europe

The new technology was designed for patients who may not be able to undergo SAVR or TAVR.

READ MORE >
Cardiawave announced the first routine clinical use in Europe of its Valvosoft system since its CE mark regulator clearance in late 2025. It is a noninvasive, high-intensity ultrasound therapy to fragment leaflet calcium in severe symptomatic aortic stenosis, and I is aimed at patients who are not ideal for surgical or transcatheter aortic valve replacement, or who decline surgical intervention.
Share on Twitter Share on Facebook Share on Linkedin

High-intensity ultrasound technology for calcified valve leaflets makes debut in Europe

Share on Twitter Share on Facebook Share on Linkedin
Cardiawave announced the first routine clinical use in Europe of its Valvosoft system since its CE mark regulator clearance in late 2025. It is a noninvasive, high-intensity ultrasound therapy to fragment leaflet calcium in severe symptomatic aortic stenosis, and I is aimed at patients who are not ideal for surgical or transcatheter aortic valve replacement, or who decline surgical intervention.
The new technology was designed for patients who may not be able to undergo SAVR or TAVR.
READ MORE >

AFib patients with gout face greater stroke risk—but therapy can help

Gout often goes undertreated, but targeting these patients with urate-lowering therapy can make a big impact on their long-term cardiovascular health.

READ MORE >
older patient with a doctor at their house
Share on Twitter Share on Facebook Share on Linkedin

AFib patients with gout face greater stroke risk—but therapy can help

Share on Twitter Share on Facebook Share on Linkedin
older patient with a doctor at their house
Gout often goes undertreated, but targeting these patients with urate-lowering therapy can make a big impact on their long-term cardiovascular health.
READ MORE >

Cardiology still one of the top specialties for FDA-cleared AI algorithms

Cardiology remains the No. 2 healthcare specialty for AI approvals, trailing only radiology. 

READ MORE >
The Boston Scientific BodyGuardian Remote Monitoring System uses AI to help detect and monitor cardiac arrhythmias in ambulatory patients.
Share on Twitter Share on Facebook Share on Linkedin

Cardiology still one of the top specialties for FDA-cleared AI algorithms

Share on Twitter Share on Facebook Share on Linkedin
The Boston Scientific BodyGuardian Remote Monitoring System uses AI to help detect and monitor cardiac arrhythmias in ambulatory patients.
Cardiology remains the No. 2 healthcare specialty for AI approvals, trailing only radiology. 
READ MORE >

Family files $17M lawsuit after young girl’s heart valve allegedly implanted upside down

Days went by and the girl's doctors never figured out what was wrong. When she was transferred to a different hospital, however, the issue was quickly identified and corrected. 

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Family files $17M lawsuit after young girl’s heart valve allegedly implanted upside down

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
Days went by and the girl's doctors never figured out what was wrong. When she was transferred to a different hospital, however, the issue was quickly identified and corrected. 
READ MORE >

CMS proposes major TAVR changes, including Medicare coverage for asymptomatic patients

After months of consideration, CMS has proposed sweeping changes to its TAVR coverage policies. The agency is accepting public comments until July 15.

READ MORE >
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
Share on Twitter Share on Facebook Share on Linkedin

CMS proposes major TAVR changes, including Medicare coverage for asymptomatic patients

Share on Twitter Share on Facebook Share on Linkedin
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.
After months of consideration, CMS has proposed sweeping changes to its TAVR coverage policies. The agency is accepting public comments until July 15.
READ MORE >

Medline recalls nearly 50K procedure kits, including many used by cardiologists

This recall was put in place due to a risk of the included adhesive not working. Nothing needs to be returned, but clinicians should not use the adhesive that comes inside the procedure kits.

READ MORE >
the words "FDA recall" on a board
Share on Twitter Share on Facebook Share on Linkedin

Medline recalls nearly 50K procedure kits, including many used by cardiologists

Share on Twitter Share on Facebook Share on Linkedin
the words "FDA recall" on a board
This recall was put in place due to a risk of the included adhesive not working. Nothing needs to be returned, but clinicians should not use the adhesive that comes inside the procedure kits.
READ MORE >

Looking ahead to the future of FFR-CT

Current research suggests this technology is just getting started when it comes to transforming patient care.

READ MORE >
An example of the image quality from the new GE Photonova photon-counting CT system, where more detailed images of soft plaque and the ability to see through heavy calcium and stents is expected to improve CT-FFR assessments.
Share on Twitter Share on Facebook Share on Linkedin

Looking ahead to the future of FFR-CT

Share on Twitter Share on Facebook Share on Linkedin
An example of the image quality from the new GE Photonova photon-counting CT system, where more detailed images of soft plaque and the ability to see through heavy calcium and stents is expected to improve CT-FFR assessments.
Current research suggests this technology is just getting started when it comes to transforming patient care.
READ MORE >

Medtronic completes $550M acquisition of neurovascular company

Scientia Vascular, a medtech company focused on advanced stroke therapies, is now officially part of Medtronic. 

READ MORE >
business partnership handshake merger acquisition M&A
Share on Twitter Share on Facebook Share on Linkedin

Medtronic completes $550M acquisition of neurovascular company

Share on Twitter Share on Facebook Share on Linkedin
business partnership handshake merger acquisition M&A
Scientia Vascular, a medtech company focused on advanced stroke therapies, is now officially part of Medtronic. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup